Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Well delve into the science behind these medications, discuss common concerns when discontinuing use, and highlight the importance of lifestyle changes alongside any medical intervention
Semaglutide the active ingredient in Ozempic and Wegovy has emerged as a game-changer for medical weight management
A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonist therapy in women with obesity and insulin resistance produced significant improvements in androgen levels, menstrual regularity, and metabolic markers, with effects most pronounced in women with baseline hyperinsulinemia, underscoring how tightly GLP-1 mechanisms are connected to broader hormonal function in women
Eli Lillys oral GLP-1, orforglipron, is also generating significant attention
Not everyone responds to semaglutide (Wegovy) in the same way
Retatrutide: low starting doses titrating up
